Search results
Moderna's CEO wants employees to use ChatGPT at least 20 times a day
Quartz· 2 weeks agoStéphane Bancel said the pharma company's partnership with OpenAI will help transform its business
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 4 days agoWith its OpenAI partnership, Moderna hopes...statement by OpenAI. Those products could range from...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 4 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 4 days agoDuring Q1 2023, Moderna received revenue from doses...was $96m, which included $8m in third-party royalties, $30m in inventory write-downs and $27m...
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
Investing.com· 4 days agoThe biotechnology company, known for its mRNA vaccine technology, highlighted its strategic...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via AOL· 4 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
At Moderna, OpenAI’s GPTs Are Changing Almost Everything
The Wall Street Journal· 2 weeks ago“People literally talk about how AI is going to cure diseases someday, and I think this is a very...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 4 days agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna and OpenAI Collaborate To Advance mRNA Medicine
San Mateo Daily Journal· 2 weeks agoCAMBRIDGE, MA AND SAN FRANCISCO, CA / ACCESSWIRE / April 24, 2024 / Moderna, Inc. (NASDAQ:MRNA) and OpenAI today announced their ongoing collaboration to ...
Moderna Focused on Cutting Costs, RSV Vaccine
Bloomberg· 4 days agoModerna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines ...
